Medication info
Nexome Tablet 20mg (Esomeprazole Magnesium Trihydrate)

Nexome Tablet 20mg (Esomeprazole Magnesium Trihydrate)

Prescription medicationTabletOral · Intravenous injection
Ingredient · strength
Esomeprazole Magnesium Trihydrate›22.3mg / 1 tablet
Manufacturer / importer
Korea Chorus Co., Ltd.
Appearance
Pale pink round film-coated tablet
Packaging
For domestic use: 14 tablets/AluAlu*2 For export: 28 tablets (14 tablets/AluAlu*2)
Approval status
Active

MFDS item code 201506736 · Approved 2015.09.23 · Insurance code 647204000

Summary

Main use
Treatment of gastroesophageal reflux disease, gastrointestinal disorders (such as ulcers and pain), and Zollinger-Ellison syndrome
Who uses it
Adults · Children
Adult dosage
Administer 40 mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, take for an additional 4 weeks. 20 mg once daily. 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. Once symptoms have resolved, control subsequent symptoms by administering 20 mg once daily. Adults may take 20 mg once daily as needed. As-needed administration is not recommended for controlling persistent symptoms in patients at high risk of developing gastric or duodenal ulcers due to nonsteroidal anti-inflammatory drug use. Administer this medicine 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. No clinical trials exceeding 4 weeks have been conducted. 20 mg once daily. The treatment period is 4∼8 weeks. 20 mg once daily. The recommended initial dose is 40 mg twice daily. The dose should then be adjusted individually, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses above 80 mg per day should be divided into 2 doses. Administer 40 mg once daily for 4 weeks after intravenous treatment to induce prevention of rebleeding due to gastric or duodenal ulcers. No dose adjustment is necessary. Use with caution because there is limited experience in patients with severe renal failure. No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, do not exceed a dose of 20 mg of this medicine. No dose adjustment is necessary.
Children's dosage
Adolescents aged 12 years and older: For the treatment of erosive reflux esophagitis, administer 40 mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, take for an additional 4 weeks. Adolescents aged 12 years and older: For symptomatic treatment of gastroesophageal reflux disease without esophagitis, 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. Adolescents aged 12 years and older: Once symptoms have resolved, control subsequent symptoms by administering 20 mg once daily. Children under 12 years: There is no experience with administration of this medicine to children under 12 years of age.

Ingredients

Manufacturer
Korea Chorus Co., Ltd.

Efficacy & effects

Treatment of gastroesophageal reflux disease, gastrointestinal disorders (such as ulcers and pain), and Zollinger-Ellison syndrome

  • Gastroesophageal reflux disease
  • erosive esophagitis
  • esophagitis
  • duodenal ulcer
  • peptic ulcer
  • upper gastrointestinal symptoms
  • pain
  • discomfort
  • burning sensation
  • gastric ulcer
  • duodenal ulcer
  • Zollinger-Ellison syndrome
View approved original text

This medicine is used for the treatment of gastroesophageal reflux disease, particularly erosive esophagitis, and for long-term maintenance therapy to prevent recurrence in patients with esophagitis. It is also utilized in combination with antibiotics for the treatment and prevention of recurrence of Helicobacter pylori positive duodenal and peptic ulcers. It is effective for treating symptoms such as pain, discomfort, and burning sensation in the upper gastrointestinal tract caused by the use of non-steroidal anti-inflammatory drugs, as well as for the treatment and prevention of gastric and duodenal ulcers. It is also used in the treatment of Zollinger-Ellison syndrome and maintenance therapy after prevention of rebleeding due to gastric or duodenal ulcers. This medicine effectively improves symptoms and recurrences of various gastrointestinal-related diseases.

Dosage and Administration

Adult dosage

Administer 40 mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, take for an additional 4 weeks. 20 mg once daily. 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. Once symptoms have resolved, control subsequent symptoms by administering 20 mg once daily. Adults may take 20 mg once daily as needed. As-needed administration is not recommended for controlling persistent symptoms in patients at high risk of developing gastric or duodenal ulcers due to nonsteroidal anti-inflammatory drug use. Administer this medicine 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. No clinical trials exceeding 4 weeks have been conducted. 20 mg once daily. The treatment period is 4∼8 weeks. 20 mg once daily. The recommended initial dose is 40 mg twice daily. The dose should then be adjusted individually, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses above 80 mg per day should be divided into 2 doses. Administer 40 mg once daily for 4 weeks after intravenous treatment to induce prevention of rebleeding due to gastric or duodenal ulcers. No dose adjustment is necessary. Use with caution because there is limited experience in patients with severe renal failure. No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, do not exceed a dose of 20 mg of this medicine. No dose adjustment is necessary.

Children's dosage

Adolescents aged 12 years and older: For the treatment of erosive reflux esophagitis, administer 40 mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, take for an additional 4 weeks. Adolescents aged 12 years and older: For symptomatic treatment of gastroesophageal reflux disease without esophagitis, 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. Adolescents aged 12 years and older: Once symptoms have resolved, control subsequent symptoms by administering 20 mg once daily. Children under 12 years: There is no experience with administration of this medicine to children under 12 years of age.

Precautions

This medication should not be administered to certain patients. For example, patients with allergies or a history of hypersensitivity to this medication or its components, patients allergic to certain antibiotics, patients with a history of myocardial infarction, and nursing mothers should not receive this medication. Additionally, patients with allergies or a history of hypersensitivity to the dye Yellow No. 5 included in this medication should use it with caution. Care is required with this medication as various adverse reactions may occur. These include blood-related problems, allergic reactions, neurological symptoms, gastrointestinal issues, liver function abnormalities, skin rashes or itching, muscle pain, kidney problems, etc. Particularly with prolonged use, electrolyte imbalances such as hypomagnesemia may occur, so it is important to have regular blood tests. This medication suppresses gastric acid secretion, which can increase the risk of bacterial infections in the digestive tract, thus if diarrhea persists, one should consult a healthcare professional immediately. Prolonged use may increase the risk of fractures, so patients at risk for osteoporosis should undergo appropriate monitoring, including bone density testing. This medication may interact with other drugs, so it is important to inform your healthcare provider, especially when taking antiviral drugs, anticoagulants, antibiotics, or anticonvulsants, and to carefully monitor for any changes in condition while taking the medication. The safety of this medication during pregnancy has not been fully established, so it is essential to consult with your physician if you are pregnant or plan to become pregnant. In cases of nursing, it is recommended to avoid breastfeeding as this medication may be passed into breast milk. In the event of an overdose, there are no specific antidotes; treatment should be administered according to symptoms and under the direction of a healthcare professional. Lastly, this medication should be kept out of the reach of children and not transferred to other containers.

Side effects

Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reactions, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggression, hallucinations, headache, dizziness, paresthesia, drowsiness, taste disturbance, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, increased liver enzymes, jaundice, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, mucocutaneous syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthemous pustulosis, drug reaction with eosinophilia and systemic symptoms, fractures, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile associated diarrhea, abdominal distension, allergic reaction, back pain, chest pain, retrosternal pain, facial edema, facial flushing, fatigue, fever, influenza-like illness, generalized edema, leg edema, malaise, pain, rigidity, anemia, hypochromic anemia, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver dysfunction, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, dry mouth, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, seizures, fibromyalgia syndrome, hernia, polymyalgia rheumatica, anorexia, apathy, increased appetite, confusion, worsening depression, hypertonia, sensory loss, erectile dysfunction, insomnia, migraine, worsening migraine, sleep disorders, tremors, visual field defects, dysmenorrhea, menstrual disorders, vaginitis, exacerbation of asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular rash, otitis media, olfactory disturbances, taste loss, taste distortion, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infection, hematuria, micturition frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyp or nodule, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, gastric fundal polyp, hypocalcemia, hypokalemia, rhabdomyolysis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, ideally at a temperature between 1°C and 30°C at room temperature. Proper storage will help maintain the medication's efficacy.

Appearance and packaging

Appearance

Pale pink round film-coated tablet

Package unit

For domestic use: 14 tablets/AluAlu*2 For export: 28 tablets (14 tablets/AluAlu*2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.